Terms: = Colorectal cancer AND TIMP1, CLGI, EPA, EPO, HCI, TIMP, TIMP-1 AND Treatment
150 results:
1. Elucidation of the anti-colorectal cancer mechanism of
Wang G; Guo C; Pi H; Wang Y; Lin S; Bi K; Zhang M; Wang N; Zhao G
Aging (Albany NY); 2024 Aug; 16(16):12008-12028. PubMed ID: 39177661
[No Abstract] [Full Text] [Related]
2. Longitudinal impact of screening colonoscopy on greenhouse gas emissions.
Yusuf H; Gupta V; Osaghae I; Kumar A
PLoS One; 2024; 19(7):e0307133. PubMed ID: 39028703
[TBL] [Abstract] [Full Text] [Related]
3. APOE genotype, eicosapentaenoic acid (epa) supplementation and n-3 highly unsaturated fatty acid (HUFA) levels in patients with multiple colorectal polyps: A secondary analysis of the seAFOod polyp prevention trial.
Sun G; Davies JR; Mell T; Harland M; Saleh RMH; Race AD; Loadman PM; Williams EA; Minihane AM; Hull MA
Prostaglandins Leukot Essent Fatty Acids; 2024 Feb; 201():102623. PubMed ID: 38823349
[TBL] [Abstract] [Full Text] [Related]
4. Investigating gene signatures associated with immunity in colon adenocarcinoma to predict the immunotherapy effectiveness using NFM and WGCNA algorithms.
Liang W; Yang X; Li X; Wang P; Zhu Z; Liu S; Xu D; Zhi X; Xue J
Aging (Albany NY); 2024 May; 16(9):7596-7621. PubMed ID: 38742936
[TBL] [Abstract] [Full Text] [Related]
5. Molecular Mechanisms Associated with the Inhibitory Role of Long Chain n-3 PUFA in colorectal cancer.
Jayathilake AG; Luwor RB; Nurgali K; Su XQ
Integr Cancer Ther; 2024; 23():15347354241243024. PubMed ID: 38708673
[TBL] [Abstract] [Full Text] [Related]
6. Which Drugs are More Effective in Preventing Familial Adenomatous Polyposis Progression based on Network Meta-analysis?
Luo P; Shi W; Cheng X; Yang J; Pei G; Dong J
Curr Pharm Des; 2024; 30(20):1548-1563. PubMed ID: 38698755
[TBL] [Abstract] [Full Text] [Related]
7. Urolithin A affects cellular migration and modulates matrix metalloproteinase expression in colorectal cancer cells.
El-Wetidy MS; Rady MI; Rady I; Helal H
Cell Biochem Funct; 2024 Apr; 42(3):e4019. PubMed ID: 38622949
[TBL] [Abstract] [Full Text] [Related]
8. Constructing a personalized prognostic risk model for colorectal cancer using machine learning and multi-omics approach based on epithelial-mesenchymal transition-related genes.
Zhang S; Fan W; He D
J Gene Med; 2024 Jan; 26(1):e3660. PubMed ID: 38282145
[TBL] [Abstract] [Full Text] [Related]
9. The Salmon Oil OmeGo Reduces Viability of colorectal cancer Cells and Potentiates the Anti-cancer Effect of 5-FU.
Pettersen CHH; Samdal H; Sætrom P; Wibe A; Hermansen E; Schønberg SA
Mar Drugs; 2023 Dec; 21(12):. PubMed ID: 38132957
[TBL] [Abstract] [Full Text] [Related]
10. Integration of single-cell transcriptomics and epigenetic analysis reveals enhancer-controlled timp1 as a regulator of ferroptosis in colorectal cancer.
Li M; Ni QY; Yu SY
Genes Genomics; 2024 Jan; 46(1):121-133. PubMed ID: 38032469
[TBL] [Abstract] [Full Text] [Related]
11. Randomised, placebo-controlled, phase 3 trial of the effect of the omega-3 polyunsaturated fatty acid eicosapentaenoic acid (epa) on colorectal cancer recurrence and survival after surgery for resectable liver metastases: epa for Metastasis Trial 2 (EMT2) study protocol.
Hull MA; Ow PL; Ruddock S; Brend T; Smith AF; Marshall H; Song M; Chan AT; Garrett WS; Yilmaz O; Drew DA; Collinson F; Cockbain AJ; Jones R; Loadman PM; Hall PS; Moriarty C; Cairns DA; Toogood GJ
BMJ Open; 2023 Nov; 13(11):e077427. PubMed ID: 38030258
[TBL] [Abstract] [Full Text] [Related]
12. Exploration of an Prognostic Signature Related to Endoplasmic Reticulum Stress in colorectal Adenocarcinoma and Their Response Targeting Immunotherapy.
Xu Y; Xie YM; Sun WS; Zi R; Lu HQ; Xiao L; Gong KM; Guo SK
Technol Cancer Res Treat; 2023; 22():15330338231212073. PubMed ID: 37920989
[No Abstract] [Full Text] [Related]
13. The effect of aspirin and eicosapentaenoic acid on urinary biomarkers of prostaglandin E
Sun G; Fuller H; Fenton H; Race AD; Downing A; Williams EA; Rees CJ; Brown LC; Loadman PM; Hull MA
Int J Cancer; 2024 Mar; 154(5):873-885. PubMed ID: 37855394
[TBL] [Abstract] [Full Text] [Related]
14. Polymorphisms in Cyclooxygenase, Lipoxygenase, and TP53 Genes Predict colorectal Polyp Risk Reduction by Aspirin in the seAFOod Polyp Prevention Trial.
Davies JR; Mell T; Fuller H; Harland M; Saleh RNM; Race AD; Rees CJ; Brown LC; Loadman PM; Downing A; Minihane AM; Williams EA; Hull MA
Cancer Prev Res (Phila); 2023 Nov; 16(11):621-629. PubMed ID: 37756582
[TBL] [Abstract] [Full Text] [Related]
15. The anoikis-related gene signature predicts survival accurately in colon adenocarcinoma.
Hu G; Li J; Zeng Y; Liu L; Yu Z; Qi X; Liu K; Yao H
Sci Rep; 2023 Aug; 13(1):13919. PubMed ID: 37626132
[TBL] [Abstract] [Full Text] [Related]
16. Construction and validation of a prognostic model for colon adenocarcinoma based on bile acid metabolism-related genes.
Luo Q; Zhou P; Chang S; Huang Z; Zeng X
Sci Rep; 2023 Aug; 13(1):12728. PubMed ID: 37543674
[TBL] [Abstract] [Full Text] [Related]
17. colorectal polyp outcomes after participation in the seAFOod polyp prevention trial: Evidence of rebound elevated colorectal polyp risk after short-term aspirin use.
Downing A; Fenton H; Nickerson C; Loadman PM; Williams EA; Rees CJ; Brown LC; Morris EJA; Hull MA
Aliment Pharmacol Ther; 2023 Sep; 58(6):562-572. PubMed ID: 37518954
[TBL] [Abstract] [Full Text] [Related]
18. The Potential of DHA as cancer Therapy Strategies: A Narrative Review of In Vitro Cytotoxicity Trials.
de Freitas Rodrigues J; Philippsen HK; Dolabela MF; Nagamachi CY; Pieczarka JC
Nutrients; 2023 Apr; 15(8):. PubMed ID: 37111226
[TBL] [Abstract] [Full Text] [Related]
19. Plasma and rectal mucosal oxylipin levels during aspirin and eicosapentaenoic acid treatment in the seAFOod polyp prevention trial.
Fuller H; Race AD; Fenton H; Burke L; Downing A; Williams EA; Rees CJ; Brown LC; Loadman PM; Hull MA
Prostaglandins Leukot Essent Fatty Acids; 2023 May; 192():102570. PubMed ID: 37003144
[TBL] [Abstract] [Full Text] [Related]
20. An epithelial-mesenchymal transition-related mRNA signature associated with the prognosis, immune infiltration and therapeutic response of colon adenocarcinoma.
Zhang Y; Li Y; Zuo Z; Li T; An Y; Zhang W
Pathol Oncol Res; 2023; 29():1611016. PubMed ID: 36910014
[No Abstract] [Full Text] [Related]
[Next]
